Citation: | Wang Yiting, Jiang Jie, Ma Li, et al. Potential value of mesenchymal stem cells and their derivatives in repairing donor liver[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 592-597. doi: 10.3969/j.issn.1674-7445.2023.04.017 |
[1] |
DE MAGNÉE C, BRUNÉE L, TAMBUCCI R, et al. Is ABO-incompatible living donor liver transplantation really a good alternative for pediatric recipients?[J]. Children (Basel), 2021, 8(7): 600. DOI: 10.3390/children8070600.
|
[2] |
SCHOLD JD, KOVAL CE, WEE A, et al. Utilization and outcomes of deceased donor SARS-CoV-2-positive organs for solid organ transplantation in the United States[J]. Am J Transplant, 2022, 22(9): 2217-2227. DOI: 10.1111/ajt.17126.
|
[3] |
NITTA S, KUSAKARI Y, YAMADA Y, et al. Conversion of mesenchymal stem cells into a canine hepatocyte-like cells by Foxa1 and Hnf4a[J]. Regen Ther, 2020, 14: 165-176. DOI: 10.1016/j.reth.2020.01.003.
|
[4] |
LUAN Y, KONG X, FENG Y. Mesenchymal stem cells therapy for acute liver failure: recent advances and future perspectives[J]. Liver Res, 2021, 5(2): 53-61.
|
[5] |
PEGTEL DM, GOULD SJ. Exosomes[J]. Annu Rev Biochem, 2019, 88: 487-514. DOI: 10.1146/annurev-biochem-013118-111902.
|
[6] |
ClinicaiTrials. Gov[EB/OL]. [2023-02-14].
|
[7] |
DU X, LI H, HAN X, et al. Mesenchymal stem cells-derived exosomal miR-24-3p ameliorates non-alcohol fatty liver disease by targeting Keap-1[J]. Biochem Biophys Res Commun, 2022, 637: 331-340. DOI: 10.1016/j.bbrc.2022.11.012
|
[8] |
CHENG L, YU P, LI F, et al. Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression[J]. Hum Cell, 2021, 34(6): 1697-1708. DOI: 10.1007/s13577-021-00593-1.
|
[9] |
KANG Y, SONG Y, LUO Y, et al. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway[J]. Free Radic Biol Med, 2022, 192: 25-36. DOI: 10.1016/j.freeradbiomed.2022.08.037.
|
[10] |
WU R, FAN X, WANG Y, et al. Mesenchymal stem cell-derived extracellular vesicles in liver immunity and therapy[J]. Front Immunol, 2022, 13: 833878. DOI: 10.3389/fimmu.2022.833878.
|
[11] |
BI Y, GUO X, ZHANG M, et al. Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice[J]. Stem Cell Res Ther, 2021, 12(1): 602. DOI: 10.1186/s13287-021-02663-5.
|
[12] |
YANG Z, XIA Q, LU D, et al. Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis[J]. Aging (Albany NY), 2020, 12(21): 21660-21673. DOI: 10.18632/aging.103962.
|
[13] |
EL-DERANY MO, ABDELHAMID SG. Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: emphasis on caspase-2 signaling inhibition[J]. Biochem Pharmacol, 2021, 190: 114624. DOI: 10.1016/j.bcp.2021.114624.
|
[14] |
WAN YM, LI ZQ, LIU C, et al. Mesenchymal stem cells reduce alcoholic hepatitis in mice via suppression of hepatic neutrophil and macrophage infiltration, and of oxidative stress[J]. PLoS One, 2020, 15(2): e0228889. DOI: 10.1371/journal.pone.0228889.
|
[15] |
SAKAI Y, FUKUNISHI S, TAKAMURA M, et al. Clinical trial of autologous adipose tissue-derived regenerative (stem) cells therapy for exploration of its safety and efficacy[J]. Regen Ther, 2021, 18: 97-101. DOI: 10.1016/j.reth.2021.04.003.
|
[16] |
LIU Y, DONG Y, WU X, et al. The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trials[J]. Stem Cell Res Ther, 2022, 13(1): 204. DOI: 10.1186/s13287-022-02882-4.
|
[17] |
SHI M, LI YY, XU RN, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial[J]. Hepatol Int, 2021, 15(6): 1431-1441. DOI: 10.1007/s12072-021-10199-2.
|
[18] |
FERNÁNDEZ AR, SÁNCHEZ-TARJUELO R, CRAVEDI P, et al. Review: ischemia reperfusion injury-a translational perspective in organ transplantation[J]. Int J Mol Sci, 2020, 21(22): 8549. DOI: 10.3390/ijms21228549.
|
[19] |
高伟东, 杨龙龙, 尹清臣. 氧化应激反应在边缘供肝肝移植缺血-再灌注损伤中的作用研究进展[J]. 器官移植, 2022, 13(1): 126-131. DOI: 10.3969/j.issn.1674-7445.2022.01.019.
GAO WD, YANG LL, YIN QC. Research progress on the role of oxidative stress in ischemia-reperfusion injury of marginal donor liver transplantation[J]. Organ Transplant, 2022, 13(1): 126-131. DOI: 10.3969/j.issn.1674-7445.2022.01.019.
|
[20] |
WU L, TIAN X, ZUO H, et al. miR-124-3p delivered by exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia-reperfusion injury in steatotic grafts[J]. J Nanobiotechnology, 2022, 20(1): 196. DOI: 10.1186/s12951-022-01407-8.
|
[21] |
YANG B, DUAN W, WEI L, et al. Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy[J]. Stem Cells Dev, 2020, 29(6): 372-379. DOI: 10.1089/scd.2019.0194.
|
[22] |
ZHANG Y, LI Y, WANG Q, et al. Attenuation of hepatic ischemia-reperfusion injury by adipose stem cell-derived exosome treatment via ERK1/2 and GSK-3β signaling pathways[J]. Int J Mol Med, 2022, 49(2): 13. DOI: 10.3892/ijmm.2021.5068.
|
[23] |
PIAO C, ZHANG Q, XU J, et al. Optimal intervention time of ADSCs for hepatic ischemia-reperfusion combined with partial resection injury in rats[J]. Life Sci, 2021, 285: 119986. DOI: 10.1016/j.lfs.2021.119986.
|
[24] |
ZHENG J, LU T, ZHOU C, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells protect liver ischemia/reperfusion injury by reducing CD154 expression on CD4+ T cells via CCT2[J]. Adv Sci (Weinh), 2020, 7(18): 1903746. DOI: 10.1002/advs.201903746.
|
[25] |
SHI M, LIU Z, WANG Y, et al. A pilot study of mesenchymal stem cell therapy for acute liver allograft rejection[J]. Stem Cells Transl Med, 2017, 6(12): 2053-2061. DOI: 10.1002/sctm.17-0134.
|
[26] |
ZHANG Y, ZHANG J, YI H, et al. A novel MSC-based immune induction strategy for ABO-incompatible liver transplantation: a phase Ⅰ/Ⅱ randomized, open-label, controlled trial[J]. Stem Cell Res Ther, 2021, 12(1): 244. DOI: 10.1186/s13287-021-02246-4.
|
[27] |
LI J, PENG Q, YANG R, et al. Application of mesenchymal stem cells during machine perfusion: an emerging novel strategy for organ preservation[J]. Front Immunol, 2021, 12: 713920. DOI: 10.3389/fimmu.2021.713920.
|
[28] |
UEMOTO S, FUJIMOTO Y, TERATANI T, et al. Introduction of mesenchymal stem cells for liver surgery (hepatectomy and transplantation)[M]// NAKAO K, MINATO N, UEMOTO S. Innovative medicine: basic research and development. Tokyo: Springer, 2015.
|
[29] |
王惠, 赵鹏翔, 张旭娟, 等. 间充质干细胞在疾病治疗中的应用潜力[J]. 生物技术进展, 2021, 11(6): 688-693. DOI: 10.19586/j.2095-2341.2021.0055.
WANG H, ZHAO PX, ZHANG XJ, et al. The application potential of mesenchymal stem cells in the treatment of diseases[J]. Current Biotechnol, 2021, 11(6): 688-693. DOI: 10.19586/j.2095-2341.2021.0055.
|
[30] |
WABITSCH S, BENZING C, KRENZIEN F, et al. Human stem cells promote liver regeneration after partial hepatectomy in Balb/c nude mice[J]. J Surg Res, 2019, 239: 191-200. DOI: 10.1016/j.jss.2019.02.010.
|
[31] |
LIU T, MU H, SHEN Z, et al. Autologous adipose tissue-derived mesenchymal stem cells are involved in rat liver regeneration following repeat partial hepatectomy[J]. Mol Med Rep, 2016, 13(3): 2053-2059. DOI: 10.3892/mmr.2016.4768.
|
[32] |
SONG XJ, ZHANG L, LI Q, et al. hUCB-MSC derived exosomal miR-124 promotes rat liver regeneration after partial hepatectomy via downregulating Foxg1[J]. Life Sci, 2021, 265: 118821. DOI: 10.1016/j.lfs.2020.118821.
|
[33] |
WANG W, DU Z, YAN J, et al. Mesenchymal stem cells promote liver regeneration and prolong survival in small-for-size liver grafts: involvement of C-Jun N-terminal kinase, cyclin D1, and NF-κB[J]. PLoS One, 2014, 9(12): e112532. DOI: 10.1371/journal.pone.0112532.
|
[34] |
HAZRATI A, MALEKPOUR K, SOUDI S, et al. Mesenchymal stromal/stem cells and their extracellular vesicles application in acute and chronic inflammatory liver diseases: emphasizing on the anti-fibrotic and immunomodulatory mechanisms[J]. Front Immunol, 2022, 13: 865888. DOI: 10.3389/fimmu.2022.865888.
|
[35] |
PIAO C, SANG J, KOU Z, et al. Effects of exosomes derived from adipose-derived mesenchymal stem cells on pyroptosis and regeneration of injured liver[J]. Int J Mol Sci, 2022, 23(20): 12065. DOI: 10.3390/ijms232012065.
|
[36] |
谢炎, 蒋文涛. 供肝保存与功能维护助力肝移植发展[J]. 器官移植, 2023, 14(2): 201-206. DOI: 10.3969/j.issn.1674-7445.2023.02.004.
XIE Y, JIANG WT. Liver graft preservation and functional maintenance accelerate the development of liver transplantation[J]. Organ Transplant, 2023, 14(2): 201-206. DOI: 10.3969/j.issn.1674-7445.2023.02.004.
|
[37] |
曹欢, 宋红丽, 沈中阳. 供肝体外保存技术的研究进展[J]. 中华肝胆外科杂志, 2020, 26(3): 229-233. DOI: 10.3760/cma.j.issn.1007-8118.2020.03.020.
CAO H, SONG HL, SHEN ZY. Progress in research on donor liver preservation technology in vitro[J]. Chin J Hepatobiliary Surg, 2020, 26(3): 229-233. DOI: 10.3760/cma.j.issn.1007-8118.2020.03.020.
|
[38] |
刘子文, 王文波. 缺氧培养调控间充质干细胞的生理活性[J]. 中国组织工程研究, 2022, 26(13): 2127-2132. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202213029.htm
WANG ZW, WANG WB. Regulatory effects of hypoxic culture on physiological activities of mesenchymal stem cells[J]. Chin J Tissue Eng Res, 2022, 26(13): 2127-2132. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202213029.htm
|
[39] |
王媞尔, 史明霞. 间充质干细胞旁分泌作用的研究进展[J]. 实用医学杂志, 2021, 37(13): 1651-1654. DOI: 10.3969/j.issn.1006-5725.2021.13.001.
WANG TR, SHI MX. Research advance in paracrine role of mesenchymal stem cells[J]. J Pract Med, 2021, 37(13): 1651-1654. DOI: 10.3969/j.issn.1006-5725.2021.13.001.
|
[40] |
YANG Y, LEE EH, YANG Z. Hypoxia-conditioned mesenchymal stem cells in tissue regeneration application[J]. Tissue Eng Part B Rev, 2022, 28(5): 966-977. DOI: 10.1089/ten.TEB.2021.0145.
|
[41] |
白佳萌, 刘光伟, 谢露, 等. 间充质干细胞及其外泌体在肝再生领域的应用[J]. 中国组织工程研究, 2022, 26(19): 3071-3077. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202219022.htm
BAI JM, LIU GW, XIE L, et al. Application of mesenchymal stem cells and exosomes in liver regeneration[J]. Chin J Tissue Eng Res, 2022, 26(19): 3071-3077. https://www.cnki.com.cn/Article/CJFDTOTAL-XDKF202219022.htm
|
[42] |
NGO ATL, LE HM, TRINH NTH, et al. Clinically relevant preservation conditions for mesenchymal stem/stromal cells derived from perinatal and adult tissue sources[J]. J Cell Mol Med, 2021, 25(22): 10747-10760. DOI: 10.1111/jcmm.17016.
|
[43] |
DETRY O, VANDERMEULEN M, DELBOUILLE MH, et al. Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase Ⅰ-Ⅱ, open-label, clinical study[J]. J Hepatol, 2017, 67(1): 47-55. DOI: 10.1016/j.jhep.2017.03.001.
|
[44] |
CASIRAGHI F, PERICO N, PODESTÀ MA, et al. Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: a randomized controlled trial[J]. Am J Transplant, 2021, 21(8): 2795-2809. DOI: 10.1111/ajt.16468.
|